You are using an older browser version. Please use a supported version for the best MSN experience.

FDA approves first treatment for postpartum depression

The FDA has approved a new medication called Zulresso, a completely new class of drug designed specifically to treat postpartum depression. It’s a one-time infusion given in a hospital over two and a half days.
image beaconimage beaconimage beacon